Neuroprotectants: The Next Frontier in Neurology

Neuroprotectants are drugs or substances that help protect the brain and nerves from damage caused by injuries or diseases like stroke, Alzheimer's disease, and Parkinson's disease. This review looks at different types of neuroprotective agents, including those that reduce inflammation, prevent cell death, or improve blood flow to the brain. While many of these substances show good results in lab studies, only a few have been successful in human trials. This is often due to problems like delayed treatment, difficulty reaching the brain, and differences between patients. The review also discusses future clinical trials and how new technologies and targeted treatments may improve outcomes. Understanding how these agents work and how to test them better could lead to more effective treatments for brain disorders.

Authors

Institutions

Publication Details

Journal
Journal of Pharmacy And Bioallied Sciences
Published
2026-01-12
DOI
https://doi.org/10.4103/jpbs.jpbs_1472_25
Primary Topic
Neurological Disease Mechanisms and Treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Neuroprotectants: The Next Frontier in Neurology

Nisha Jayantilal Parmar, Patel Khushi, Jyotsna Sethumadhavan, Pallavi Kamlesh Kale et al.
Journal of Pharmacy And Bioallied Sciences
Neurological Disease Mechanisms and Treatments
article

Neuroprotectants: The Next Frontier in Neurology

Nisha Jayantilal Parmar, Patel Khushi, Jyotsna Sethumadhavan, Pallavi Kamlesh Kale, Rashmi Laddha, Rahul G. Daga
article en

Abstract

Neuroprotectants are drugs or substances that help protect the brain and nerves from damage caused by injuries or diseases like stroke, Alzheimer's disease, and Parkinson's disease. This review looks at different types of neuroprotective agents, including those that reduce inflammation, prevent cell death, or improve blood flow to the brain. While many of these substances show good results in lab studies, only a few have been successful in human trials. This is often due to problems like delayed treatment, difficulty reaching the brain, and differences between patients. The review also discusses future clinical trials and how new technologies and targeted treatments may improve outcomes. Understanding how these agents work and how to test them better could lead to more effective treatments for brain disorders.

Journal of Pharmacy And Bioallied SciencesVol. 18(Suppl 1)
Dharmsinh Desai University (IN), Sardar Vallabhbhai National Institute of Technology Surat (IN), Indira Gandhi Government Medical College & Hospital (IN), SMT (India) (IN), Govt. Dental College & Hospital (IN), Bharati Vidyapeeth (Deemed to be University) (IN)
Good health and well-being
Openalex Percentile: Top 92%
Neurological Disease Mechanisms and Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.